Form 8-K - Current report:
SEC Accession No. 0001104659-25-044240
Filing Date
2025-05-02
Accepted
2025-05-02 17:25:19
Documents
14
Period of Report
2025-04-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513449d1_8k.htm   iXBRL 8-K 29262
2 EXHIBIT 3.1 tm2513449d1_ex3-1.htm EX-3.1 8916
  Complete submission text file 0001104659-25-044240.txt   219832

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20250428.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20250428_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20250428_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2513449d1_8k_htm.xml XML 3929
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 25910116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)